Implications for matrix metalloproteinases as modulators of pediatric lung disease

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 284, Issue 4 28-4, 2003, Pages

  Winkler, Margaret K ^a,d   Foldes, Jane K ^b   Bunn, Robert C ^c   Fowlkes, John L ^c  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d CHILDREN S HOSPITAL OF ALABAMA   (United States)

Author keywords

Bronchoalveolar lavage; Extracellular matrix

Indexed keywords

GELATINASE; GELATINASE B; MATRILYSIN; MATRIX METALLOPROTEINASE; NEUTROPHIL COLLAGENASE;

ADOLESCENT; ARTICLE; ARTIFICIAL VENTILATION; ASPIRATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; INFANT; LUNG DISEASE; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY FAILURE;

EID: 0037379025     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00195.2002     Document Type: Article

References (39)

1. Betsuyaku T, Fukuda Y, Parks WC, Shipley JM, and Senior RM. Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin. Am J Pathol 157: 525-535, 2000.
2. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, and Engler JA. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4: 197-250, 1993.
3. Cawston T, Carrere S, Catterall J, Duggleby R, Elliott S, Shingleton B, and Rowan A. Matrix metalloproteinases and TIMPs: properties and implications for the treatment of chronic obstructive pulmonary disease. Novartis Found Symp 234: 205-218; discussion 218-228, 2001.
4. Cederqvist K, Sorsa T, Tervahartiala T, Maisi P, Reunanen K, Lassus P, and Andersson S. Matrix metalloproteinases-2, -8, and -9 and TIMP-2 in tracheal aspirates from preterm infants with respiratory distress. Pediatrics 108: 686-692, 2001.
5. Chubinskaya S, Huch K, Mikecz K, Cs-Szabo G, Hasty KA, Kuettner KE, and Cole AA. Chondrocyte matrix metalloproteinase-8: upregulation of neutrophil collagenase by interleukin-1 β in human cartilage from knee and ankle joints. Lab Invest 74: 232-240, 1996.
6. Corbel M, Boichot E, and Lagente V. Role of gelatinases MMP-2 and MMP-9 in tissue remodeling following acute lung injury. Braz J Med Biol Res 33: 749-754, 2000.
7. Dunsmore SE, Saarialho-Kere UK, Roby JD, Wilson CL, Matrisian LM, Welgus HG, and Parks WC. Matrilysin expression and function in airway epithelium. J Clin Invest 102: 1321-1331, 1998.
8. Fowlkes J and Winkler M. Exploring the interface between metallo-proteinase activity and growth factor and cytokine bioavailability. Cytokine Growth Factor Rev 13: 277-287, 2002.
9. Fowlkes JL, Enghild JJ, Suzuki K, and Nagase H. Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. J Biol Chem 269: 25742-25746, 1994.
10. Fukuda Y, Ishizaki M, Okada Y, Seiki M, and Yamanaka N. Matrix metalloproteinases and tissue inhibitor of metalloproteinase-2 in fetal rabbit lung. Am J Physiol Lung Cell Mol Physiol 279: L555-L561, 2000.
11. Hanemaaijer R, Sorsa T, Konttinen YT, Ding Y, Sutinen M, Visser H, van Hinsbergh VW, Helaakoski T, Kainulainen T, Ronka H, Tschesche H, and Salo T. Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-α and doxycycline. J Biol Chem 272: 31504-31509, 1997.
12. Herbert CA, Arthur MJ, and Robinson C. Augmentation by eosinophils of gelatinase activity in the airway mucosa: comparative effects as a putative mediator of epithelial injury. Br J Pharmacol 117: 667-674, 1996.
13. Kelly EA, Busse WW, and Jarjour NN. Increased matrix metalloproteinase-9 in the airway after allergen challenge. Am J Respir Crit Care Med 162: 1157-1161, 2000.
14. Lee WL and Downey GP. Neutrophil activation and acute lung injury. Curr Opin Crit Care 7: 1-7, 2001.
15. Lee YC, Lee HB, Rhee YK, and Song CH. The involvement of matrix metalloproteinase-9 in airway inflammation of patients with acute asthma. Clin Exp Allergy 31: 1623-1630, 2001.
16. Lopez-Boado YS, Wilson CL, Hooper LV, Gordon JI, Hultgren SJ, and Parks WC. Bacterial exposure induces and activates matrilysin in mucosal epithelial cells. J Cell Biol 148: 1305-1315, 2000.
17. Matrisian LM. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6: 121-125, 1990.
18. Merritt TA, Cochrane CG, Holcomb K, Bohl B, Hallman M, Strayer D, Edwards DK III, and Gluck L. Elastase and α-1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia. J Clin Invest 72: 656-666, 1983.
19. Nagase H and Woessner JF Jr. Matrix metalloproteinases. J Biol Chem 274: 21491-21494, 1999.
20. Nicolai T. Pediatric bronchoscopy. Pediatr Pulmonol 31: 150-164, 2001.
21. Parks WC and Shapiro SD. Matrix metalloproteinases in lung biology. Respir Res 2: 10-19, 2001.
22. Prikk K, Maisi P, Pirila E, Sepper R, Salo T, Wahlgren J, and Sorsa T. In vivo collagenase-2 (MMP-8) expression by human bronchial epithelial cells and monocytes/macrophages in bronchiectasis. J Pathol 194: 232-238, 2001.
23. Quesada AR, Barbacid MM, Mira E, Fernandez-Resa P, Marquez G, and Aracil M. Evaluation of fluorometric and zymographic methods as activity assays for stromelysins and gelatinases. Clin Exp Metastasis 15: 26-32, 1997.
24. Russell RE, Culpitt SV, and DeMatos C, Donnelly L, Smith M, Wiggins J, and Barnes PJ. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 26: 602-609, 2002.
25. Segura-Valdez L, Pardo A, Gaxiola M, Uhal BD, Becerril C, and Selman M. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest 117: 684-694, 2000.
26. Shapiro SD. Diverse roles of macrophage matrix metalloproteinases in tissue destruction and tumor growth. Thromb Haemost 82: 846-849, 1999.
27. Shapiro SD, Campbell EJ, Kobayashi DK, and Welgus HG. Dexamethasone selectively modulates basal and lipopolysaccharide-induced metalloproteinase and tissue inhibitor of metalloproteinase production by human alveolar macrophages. J Immunol 146: 2724-2729, 1991.
28. Shapiro SD and Senior RM. Matrix metalloproteinases. Matrix degradation and more. Am J Respir Cell Mol Biol 20: 1100-1102, 1999.
29. Suga M, Iyonaga K, Okamoto T, Gushima Y, Miyakawa H, Akaike T, and Ando M. Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias. Am J Respir Crit Care Med 162: 1949-1956, 2000.
30. Sweet DG, McMahon KJ, Curley AE, O'Connor CM, and Halliday HL. Type I collagenases in bronchoalveolar lavage fluid from preterm babies at risk of developing chronic lung disease. Arch Dis Child Fetal Neonatal Ed 84: F168-F171, 2001.
31. Sweet DG, Wilbbourn MS, Warner JA, Howarth P, and Halliday HL. Matrix metalloproteinases in bronchoalveolar lavage fluid from preterm infants at high risk of developing bronchopulmonary dysplasia. Biol Neonate 74: 43-56, 1998.
32. Tanaka H, Miyazaki N, Oashi K, Tanaka S, Ohmichi M, and Abe S. Sputum matrix metalloproteinase-9: tissue inhibitor of metalloproteinase-1 ratio in acute asthma. J Allergy Clin Immunol 105: 900-905, 2000.
33. Thrailkill KM, Kumar S, Rosenberg CK, Auten KJ, and Fowlkes JL. Characterization of matrix metalloproteinases in human urine: alterations during adolescence. Pediatr Nephrol 13: 223-229, 1999.
34. Todd DA, Earl M, Lloyd J, Greenberg M, and John E. Cytological changes in endotracheal aspirates associated with chronic lung disease. Early Hum Dev 51: 13-22, 1998.
35. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 320: 365-376, 1989.
36. Wilson CL, Ouellette AJ, Satchell DP, Ayabe T, Lopez-Boado YS, Stratman JL, Hultgren SJ, Matrisian LM, and Parks WC. Regulation of intestinal α-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 286: 113-117, 1999.
37. Winkler M and Fowlkes J. Metalloproteinase and growth factor interactions: do they play a role in pulmonary fibrosis? Am J Physiol Lung Cell Mol Physiol 283: L1-L11, 2002.
38. Woessner JF Jr. The family of matrix metalloproteinases. Ann NYAcad Sci 732: 11-21, 1994.
39. Zucker S, Hymowitz M, Conner C, Zarrabi HM, Hurewitz AN, Matrisian L, Boyd D, Nicolson G, and Montana S. Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications. Ann NY Acad Sci 878: 212-227, 1999.